615 related articles for article (PubMed ID: 30868422)
1. Aging, comorbidities, and the importance of finding biomarkers for HIV-associated neurocognitive disorders.
Rosenthal J; Tyor W
J Neurovirol; 2019 Oct; 25(5):673-685. PubMed ID: 30868422
[TBL] [Abstract][Full Text] [Related]
2. Vascular cognitive impairment and HIV-associated neurocognitive disorder: a new paradigm.
Cysique LA; Brew BJ
J Neurovirol; 2019 Oct; 25(5):710-721. PubMed ID: 30635846
[TBL] [Abstract][Full Text] [Related]
3. The current understanding of overlap between characteristics of HIV-associated neurocognitive disorders and Alzheimer's disease.
Rubin LH; Sundermann EE; Moore DJ
J Neurovirol; 2019 Oct; 25(5):661-672. PubMed ID: 30671777
[TBL] [Abstract][Full Text] [Related]
4. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
[TBL] [Abstract][Full Text] [Related]
5. Neuropsychological Assessment of 412 HIV-Infected Individuals in São Paulo, Brazil.
Gascón MRP; Vidal JE; Mazzaro YM; Smid J; Marcusso RMN; Capitão CG; Coutinho EM; Benute GRG; De Lucia MCS; de Oliveira ACP
AIDS Patient Care STDS; 2018 Jan; 32(1):1-8. PubMed ID: 29323557
[TBL] [Abstract][Full Text] [Related]
6. Changing clinical phenotypes of HIV-associated neurocognitive disorders.
Sacktor N
J Neurovirol; 2018 Apr; 24(2):141-145. PubMed ID: 28752495
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic biomarkers for HAND.
McLaurin KA; Booze RM; Mactutus CF
J Neurovirol; 2019 Oct; 25(5):686-701. PubMed ID: 30607890
[TBL] [Abstract][Full Text] [Related]
8. Microvascular Function in Aging Among Women Living with HIV.
Monsuez JJ; Belin C; Bouchaud O
Curr HIV/AIDS Rep; 2016 Dec; 13(6):392-398. PubMed ID: 27709330
[TBL] [Abstract][Full Text] [Related]
9. Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals.
Clark US; Cohen RA
Curr Opin Investig Drugs; 2010 Aug; 11(8):884-900. PubMed ID: 20721831
[TBL] [Abstract][Full Text] [Related]
10. Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications.
Hong S; Banks WA
Brain Behav Immun; 2015 Mar; 45():1-12. PubMed ID: 25449672
[TBL] [Abstract][Full Text] [Related]
11. Beneficial and Adverse Effects of cART Affect Neurocognitive Function in HIV-1 Infection: Balancing Viral Suppression against Neuronal Stress and Injury.
Yuan NY; Kaul M
J Neuroimmune Pharmacol; 2021 Mar; 16(1):90-112. PubMed ID: 31385157
[TBL] [Abstract][Full Text] [Related]
12. The far-reaching HAND of cART: cART effects on astrocytes.
Gonzalez H; Podany A; Al-Harthi L; Wallace J
J Neuroimmune Pharmacol; 2021 Mar; 16(1):144-158. PubMed ID: 32147775
[TBL] [Abstract][Full Text] [Related]
13. No support for premature central nervous system aging in HIV-1 when measured by cerebrospinal fluid phosphorylated tau (p-tau).
Krut JJ; Price RW; Zetterberg H; Fuchs D; Hagberg L; Yilmaz A; Cinque P; Nilsson S; Gisslén M
Virulence; 2017 Jul; 8(5):599-604. PubMed ID: 27435879
[TBL] [Abstract][Full Text] [Related]
14. HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment.
Chan P; Brew BJ
Curr HIV/AIDS Rep; 2014 Sep; 11(3):317-24. PubMed ID: 24966139
[TBL] [Abstract][Full Text] [Related]
15. HIV-associated neurological disorders: a guide to pharmacotherapy.
Tan IL; McArthur JC
CNS Drugs; 2012 Feb; 26(2):123-34. PubMed ID: 22201342
[TBL] [Abstract][Full Text] [Related]
16. Does HIV infection contribute to increased beta-amyloid synthesis and plaque formation leading to neurodegeneration and Alzheimer's disease?
Fulop T; Witkowski JM; Larbi A; Khalil A; Herbein G; Frost EH
J Neurovirol; 2019 Oct; 25(5):634-647. PubMed ID: 30868421
[TBL] [Abstract][Full Text] [Related]
17. Motor function declines over time in human immunodeficiency virus and is associated with cerebrovascular disease, while HIV-associated neurocognitive disorder remains stable.
M Elicer I; Byrd D; Clark US; Morgello S; Robinson-Papp J
J Neurovirol; 2018 Aug; 24(4):514-522. PubMed ID: 29696578
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of age-related HIV neurodegeneration.
Mackiewicz MM; Overk C; Achim CL; Masliah E
J Neurovirol; 2019 Oct; 25(5):622-633. PubMed ID: 30790184
[TBL] [Abstract][Full Text] [Related]
19. Brain and liver pathology, amyloid deposition, and interferon responses among older HIV-positive patients in the late HAART era.
Solomon IH; De Girolami U; Chettimada S; Misra V; Singer EJ; Gabuzda D
BMC Infect Dis; 2017 Feb; 17(1):151. PubMed ID: 28212619
[TBL] [Abstract][Full Text] [Related]
20. Interrogating the impact of combination antiretroviral therapies on HIV-associated neurocognitive disorders.
Sharma I
HIV Med; 2021 Oct; 22(9):783-790. PubMed ID: 34291558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
